Mnet, Inquiry Disclosure Request Regarding Rumors of Acquiring Myeongmun Pharmaceutical
[Asia Economy Reporter Gong Byung-sun] On the 3rd, the Korea Exchange KOSDAQ Market Division requested an inquiry disclosure from M2N regarding rumors of acquiring Myungmoon Pharmaceutical. On the same day, the Korea Exchange KOSPI Market Division also requested an inquiry disclosure from Myungmoon Pharmaceutical concerning rumors of the largest shareholder's stake sale.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
- Brilliant Korean Technology Flows Overseas... Subsidies Granted, but "No Product Launch Allowed"
- Singer Kim Minjong Responds to MC Mong's Gambling Allegations: "Clearly False... Legal Action to Follow"
- Instead of a Lawmaker Profile, Now a 'Carpenter'...Ryu Hojung Says "I Can't Do a Body Profile Twice"
The deadline for response is by 12:00 PM on the 4th.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Candy, Yet Impossible to Find... Fears of a 'Pediatric Medical Crisis' as Pharmaceutical Companies Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
